Intellia Therapeutics Inc buy BenchmarkLong70
Start price
29.10.24
/
50%
€15.30
Target price
29.11.24
-
Performance (%)
-2.62%
End price
30.11.24
€14.90
Summary
This prediction ended on 30.11.24 with a price of €14.90. With a performance of -2.62%, the BUY prediction by BenchmarkLong70 finished with a loss. BenchmarkLong70 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -1.332% | -1.332% | -10.751% |
| iShares Core DAX® | 3.901% | 2.667% | 5.690% |
| iShares Nasdaq 100 | -2.603% | -7.934% | 19.505% |
| iShares Nikkei 225® | -0.545% | -9.754% | 46.053% |
| iShares S&P 500 | -0.881% | -1.488% | 16.911% |
Comments by BenchmarkLong70 for this prediction
In the thread Trading Intellia Therapeutics Inc
Die von BenchmarkLong70 gewählte maximale Laufzeit wurde überschritten